Literature DB >> 8384312

Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2.

D P Cerretti1, C J Kozlosky, T Vanden Bos, N Nelson, D P Gearing, M P Beckmann.   

Abstract

Interleukin-8 (IL-8), neutrophil activating peptide-2 (NAP-2), and growth regulated gene (GRO, also known as melanoma growth stimulatory activity) are members of a family of peptides which are chemotactic agents for inflammatory cells such as neutrophils. Receptors have been identified for IL-8, GRO and NAP-2 on human neutrophils and granulocytic cell lines, and it has been observed that these cytokines can cross-compete for binding to a common receptor. Using the recently characterized rabbit IL-8 receptor as a probe, two classes of cDNAs, termed type 1 and type 2, were isolated from a human neutrophil library. The type 1 receptor binds only IL-8 while the type 2 receptor binds IL-8, GRO and NAP-2 at high affinity when respective cDNAs are expressed in COS-7 cells. The two cDNAs encode proteins that have an amino acid sequence identity of 77% while the type 1 and 2 receptors have an identity of 84 and 74% with the rabbit IL-8 receptor. These receptors also show significant homology with receptors for other chemotactic agents and with potential coding regions from the human cytomegalovirus genome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384312     DOI: 10.1016/0161-5890(93)90065-j

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  14 in total

1.  Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.

Authors:  Gina Lee; Brian K Gardner; David A Elashoff; Colleen M Purcell; Harpavan S Sandha; Jenny T Mao; Kostyantyn Krysan; Jay M Lee; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2011-04-02       Impact factor: 4.060

2.  Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype.

Authors:  Aihua Li; Michelle L Varney; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.

Authors:  L F Jerva; G Sullivan; E Lolis
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

Review 4.  Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis.

Authors:  Wen-Jun Jin; Jin-Ming Xu; Wen-Li Xu; Dong-Hua Gu; Pei-Wei Li
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).

Authors:  Ronald S Boshuizen; Catherine Marsden; Johan Turkstra; Christine J Rossant; Jerry Slootstra; Clive Copley; Klaus Schwamborn
Journal:  MAbs       Date:  2014       Impact factor: 5.857

6.  Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

Authors:  Dean Y Maeda; Mark T Quinn; Igor A Schepetkin; Liliya N Kirpotina; John A Zebala
Journal:  J Pharmacol Exp Ther       Date:  2009-09-24       Impact factor: 4.030

7.  SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.

Authors:  M E Bradley; M E Bond; J Manini; Z Brown; S J Charlton
Journal:  Br J Pharmacol       Date:  2009-04-24       Impact factor: 8.739

8.  Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors.

Authors:  J Norgauer; B Metzner; W Czech; I Schraufstatter
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

9.  Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair.

Authors:  L B Nanney; S G Mueller; R Bueno; S C Peiper; A Richmond
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

10.  Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.

Authors:  H E Broxmeyer; S Cooper; N Hague; L Benninger; A Sarris; K Cornetta; S Vadhan-Raj; P Hendrie; C Mantel
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.